Position in SUPN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$14,243,747
+$746,520 QoQ
Shares Held
275,561
+1.5% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $249,167,464 across 9 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,214,123 | $143,521,479 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
5,040,670 | $47,987,178 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
373,634 | $17,990,476 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
206,123 | $15,850,858 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
275,561 | $14,243,747 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
163,497 | $4,924,527 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
17,300 | $2,279,101 | |
| 8 | VTRS |
Viatris Inc
|
155,945 | $2,106,816 |
All Filings in SUPN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,243,747 | 275,561 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $13,497,227 | 271,574 | Shares | Defined | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||